Brachytherapy May Be Underused

Share this content:

Brachytherapy appears to have significant advantages over EBRT in the treatment of men with low-risk and intermediate-risk prostate cancer. John Schieszer reports in today's Medical Minute that new data from the Cleveland Clinic suggest that brachytherapy may be underused.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters